Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model
Open Access
- 5 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8), e70395
- https://doi.org/10.1371/journal.pone.0070395
Abstract
Interstitial fluid is a solution that bathes and surrounds the human cells and provides them with nutrients and a way of waste removal. It is generally believed that elevated tumor interstitial fluid pressure (IFP) is partly responsible for the poor penetration and distribution of therapeutic agents in solid tumors, but the complex interplay of extravasation, permeabilities, vascular heterogeneities and diffusive and convective drug transport remains poorly understood. Here we consider–with the help of a theoretical model–the tumor IFP, interstitial fluid flow (IFF) and its impact upon drug delivery within tumor depending on biophysical determinants such as vessel network morphology, permeabilities and diffusive vs. convective transport. We developed a vascular tumor growth model, including vessel co-option, regression, and angiogenesis, that we extend here by the interstitium (represented by a porous medium obeying Darcy's law) and sources (vessels) and sinks (lymphatics) for IFF. With it we compute the spatial variation of the IFP and IFF and determine its correlation with the vascular network morphology and physiological parameters like vessel wall permeability, tissue conductivity, distribution of lymphatics etc. We find that an increased vascular wall conductivity together with a reduction of lymph function leads to increased tumor IFP, but also that the latter does not necessarily imply a decreased extravasation rate: Generally the IF flow rate is positively correlated with the various conductivities in the system. The IFF field is then used to determine the drug distribution after an injection via a convection diffusion reaction equation for intra- and extracellular concentrations with parameters guided by experimental data for the drug Doxorubicin. We observe that the interplay of convective and diffusive drug transport can lead to quite unexpected effects in the presence of a heterogeneous, compartmentalized vasculature. Finally we discuss various strategies to increase drug exposure time of tumor cells.This publication has 50 references indexed in Scilit:
- The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systemsJournal of Theoretical Biology, 2013
- Vascular remodelling of an arterio-venous blood vessel network during solid tumour growthJournal of Theoretical Biology, 2009
- Homeostatic competition drives tumor growth and metastasis nucleationHFSP Journal, 2009
- Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulationJournal of Mathematical Biology, 2008
- Vascular targeted therapies in oncologyCell and tissue research, 2008
- Emergent vascular network inhomogeneities and resulting blood flow patterns in a growing tumorJournal of Theoretical Biology, 2008
- Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical ModelCancer Research, 2007
- Modeling the effects of vasculature evolution on early brain tumor growthJournal of Theoretical Biology, 2006
- Vascular network remodeling via vessel cooption, regression and growth in tumorsJournal of Theoretical Biology, 2006
- The Hallmarks of CancerCell, 2000